Amgen breaks ground on next-generation biomanufacturing plant in Rhode Island

Amgen broke ground on a new next-generation biomanufacturing plant at its West Greenwich, Rhode Island campus. The company expects to invest up to $200 million in the 120,000 square foot facility, which will use innovative technologies to produce medicines for U.S. and global markets.

“We are working to extend that advantage even further with a next-generation biomanufacturing plant in Rhode Island that will produce medicines to serve patients around the world.”amgen.com

• 1 source
• amgen.comAmgen Breaks Ground On Next-Generation ...Jul 31, 2018

Summarized from public sources; check the original articles before acting on it.